Free Trial
NYSE:CLB

Core Laboratories (CLB) Stock Price, News & Analysis

Core Laboratories logo
$18.90
0.00 (0.00%)
(As of 11/1/2024 ET)

About Core Laboratories Stock (NYSE:CLB)

Key Stats

Today's Range
$18.75
$19.35
50-Day Range
$16.52
$20.11
52-Week Range
$13.82
$25.13
Volume
260,108 shs
Average Volume
430,101 shs
Market Capitalization
$887.36 million
P/E Ratio
29.08
Dividend Yield
0.21%
Price Target
$17.00
Consensus Rating
Reduce

Company Overview

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Core Laboratories Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
27th Percentile Overall Score

CLB MarketRank™: 

Core Laboratories scored higher than 27% of companies evaluated by MarketBeat, and ranked 229th out of 263 stocks in the oils/energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Core Laboratories has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no buy ratings, 2 hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    Core Laboratories has only been the subject of 1 research reports in the past 90 days.

  • Read more about Core Laboratories' stock forecast and price target.
  • Earnings Growth

    Earnings for Core Laboratories are expected to grow by 36.36% in the coming year, from $0.77 to $1.05 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Core Laboratories is 29.08, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 128.03.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Core Laboratories is 29.08, which means that it is trading at a more expensive P/E ratio than the Oils/Energy sector average P/E ratio of about 12.50.

  • Price to Earnings Growth Ratio

    Core Laboratories has a PEG Ratio of 1.34. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Core Laboratories has a P/B Ratio of 3.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Core Laboratories' valuation and earnings.
  • Percentage of Shares Shorted

    15.04% of the float of Core Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Core Laboratories has a short interest ratio ("days to cover") of 17.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Core Laboratories has recently increased by 1.90%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Core Laboratories has a dividend yield of 0.21%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Core Laboratories does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Core Laboratories is 6.15%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.81% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.

  • Read more about Core Laboratories' dividend.
  • Percentage of Shares Shorted

    15.04% of the float of Core Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Core Laboratories has a short interest ratio ("days to cover") of 17.5, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Core Laboratories has recently increased by 1.90%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Core Laboratories has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Oils/Energy companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Core Laboratories this week, compared to 3 articles on an average week.
  • Search Interest

    Only 2 people have searched for CLB on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Core Laboratories insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.76% of the stock of Core Laboratories is held by insiders.

  • Percentage Held by Institutions

    97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Core Laboratories' insider trading history.
Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Stock News Headlines

Core Laboratories (NYSE:CLB) Rating Increased to Hold at StockNews.com
Evercore ISI Remains a Hold on Core Laboratories (CLB)
Nvidia warning urgent
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Core Laboratories reports Q3 ex-items EPS 25c, consensus 23c
Core Laboratories Reports Strong Q3 2024 Financial Growth
CORE LAB REPORTS THIRD QUARTER 2024 RESULTS
See More Headlines

CLB Stock Analysis - Frequently Asked Questions

Core Laboratories' stock was trading at $17.66 at the beginning of 2024. Since then, CLB shares have increased by 7.0% and is now trading at $18.90.
View the best growth stocks for 2024 here
.

Core Laboratories Inc. (NYSE:CLB) announced its earnings results on Wednesday, October, 23rd. The oil and gas company reported $0.25 EPS for the quarter, topping analysts' consensus estimates of $0.21 by $0.04. The company's revenue was up 7.2% on a year-over-year basis.

Core Laboratories' top institutional shareholders include Boston Trust Walden Corp (1.28%), Van ECK Associates Corp (0.89%), Principal Financial Group Inc. (0.47%) and Confluence Investment Management LLC (0.29%).
View institutional ownership trends
.

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Ex-Dividend for 8/26 Dividend
8/05/2024
Dividend Payable
8/26/2024
Last Earnings
10/23/2024
Today
11/02/2024
Ex-Dividend for 11/25 Dividend
11/04/2024
Dividend Payable
11/25/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
1/29/2025

Industry, Sector and Symbol

Industry
Oil & gas field services, not elsewhere classified
Sub-Industry
Petroleum And Natural Gas
Fax
N/A
Employees
3,600
Year Founded
1936

Price Target and Rating

Average Stock Price Target
$17.00
High Stock Price Target
$22.00
Low Stock Price Target
$14.00
Potential Upside/Downside
-10.0%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
4 Analysts

Profitability

Net Income
$36.67 million
Pretax Margin
8.72%

Debt

Sales & Book Value

Annual Sales
$509.79 million
Cash Flow
$1.04 per share
Book Value
$5.46 per share

Miscellaneous

Free Float
46,593,000
Market Cap
$886.89 million
Optionable
Optionable
Beta
2.36

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (NYSE:CLB) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners